Results 241 to 250 of about 74,318 (299)
Some of the next articles are maybe not open access.

Neuropeptide Y (NPY)

Pulmonary Pharmacology & Therapeutics, 2004
Neuropeptides such as neuropeptide Y (NPY) have long been proposed to play a role in the pathogenesis of inflammatory diseases. NPY is a 36 amino acid neuropeptide which participates in the regulation of a large number of physiological and pathophysiological processes in the cardiorespiratory system, immune system, nervous system and endocrine system ...
Groneberg, David A.   +4 more
openaire   +2 more sources

Cachexia and neuropeptide Y

Nutrition, 2008
Cachexia or wasting disease occurs commonly in diseases that have an overproduction of proinflammatory cytokines associated with them. The hallmarks of cachexia are loss of lean and adipose tissue, anorexia, anemia, memory disturbance, and sickness behavior.
Morley, J., Farr, S.
openaire   +3 more sources

Synthesis of neuropeptide Y*

International Journal of Peptide and Protein Research, 1987
Neuropeptide Y (NPY), a hexatriacontapeptide amide, was synthesized on benzhydrylamine resin. The peptide product obtained by HF treatment contained 63% of the target peptide, NPY. A comparison of the chemical, immuno‐chemical and biological properties of the synthetic peptide with natural NPY indicated that they were identical.
A, Balasubramaniam   +6 more
openaire   +2 more sources

Neuropeptide Y and sleep

Sleep Medicine Reviews, 2010
Neuropeptide Y (NPY), a 36-amino-acid peptide from the pancreatic polypeptide family, is one of the more abundant peptides in the central nervous system. It acts as a neurohormone and as a neuromodulator. NPY is widely distributed in the brain, particularly the hypothalamus, the amygdala, the locus coeruleus and the cerebral cortex.
Dyzma, Michal   +3 more
openaire   +3 more sources

Radioimmunoassay of neuropeptide Y

Regulatory Peptides, 1984
The development of a radioimmunoassay to the newly isolated peptide, neuropeptide Y is described. Four separate antisera have been developed using different immunisation schedules. Two of these antisera (YNI and YNIO) are directed to the C-terminal region of the peptide and cross-react with the related peptide PYY, whereas YN7 is specific being ...
J M, Allen   +3 more
openaire   +2 more sources

Neuropeptide Y

Journal of Hypertension, 1995
To evaluate whether neuropeptide Y (NPY) is likely to be relevant as a regulator of cardiovascular function in general and of blood pressure control in arterial hypertension in particular, based on a literature survey.NPY is a putative cotransmitter of many central and peripheral sympathetic neurons.
M C, Michel, W, Rascher
openaire   +2 more sources

Neuropeptide Y effector systems: perspectives for drug development

open access: yesTrends in Pharmacological Sciences, 1994
Neuropeptide Y was isolated in 1982 and has since attracted considerable interest. It is widely distributed in central and peripheral neurones and can produce a multitude of biological effects in the brain and the periphery.
Lars Grundemar   +2 more
exaly   +2 more sources

Neuropeptide Y is a vasoconstrictor and adrenergic modulator in the hamster microcirculation by acting on neuropeptide Y1 and Y2 receptors

open access: yesEuropean Journal of Pharmacology, 1995
The microvascular effects of neuropeptide Y, and two analogs with preferential affinity for different neuropeptide Y receptor subtypes, were assessed by intravital microscopy on the hamster cheek pouch.
Mauricio P Boric   +2 more
exaly   +1 more source

Home - About - Disclaimer - Privacy